One of the largest vendors providing regulatory review solutions, research quality, compliance consulting services, and clinical site technologies, recently shared the publication of The State of Clinical Trial Activation at Sites, a report providing actionable solutions to streamline study activation and maximize operational efficiency. The report is based on a survey Advarra conducted in late 2020. Industry data suggest that it can take over 180 days to activate a clinical research study, and the process continues to get longer. The longer it takes for a new therapy to reach the market, the more time and resources research sites use, and these delays potentially hinder their chances of being selected for future trials. Additionally, sponsors are trying to solve mission-critical challenges to bring life-changing therapies to patients faster. In the meantime, the site world faces growing pressures, from competitive forces due to consolidation to growing demands for investment in sophisticated technology infrastructure.
The Advarra Trial Site Survey
In an attempt to learn more about study activation challenges, Advarra surveyed clinical research professionals from a...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).